Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Cutting expenses while finding ways to make cash can greatly assist in managing debt. Explore effective strategies to boost your savings and income.
28,655 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Alphabet's Gemini 3.5 showcases bold AI ambitions, but the stock is sliding as investors reassess ROI and token-based...
Tesla delivered 480,126 vehicles in Q2 2026, topping estimates by 74,000 and signaling a rebound in EV demand. The fo...
AMD faces another round of upgrades as AI infrastructure spending keeps demand alive. Analysts raise targets while in...
Salesforce CRM faces a sharp sell-off even as its AI strategy shows real monetization. Here’s why traders are watchin...
Jim Cramer advises investors to wait before buying Vertiv after a pronounced dip, arguing that selling pressure could...
UPS sinks about 11% after weaker quarterly results, while FedEx surges past UPS in market value following a stronger ...
QuantumScape reports its first 2025 customer billings and a major monetization milestone, triggering a roughly 5% sto...
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
AST SpaceMobile posted disappointing quarterly revenue in after-hours trading, triggering a drop in spacemobile’s sto...
Broadcom reports a surge in AI semiconductor revenue and points to a path beyond $100 billion in AI-chip sales by 202...
Palantir posted solid Q1 2026 growth, but the stock fell as investors priced in a valuation reset and AI competition....